IQVIA Holdings (IQV) Traded Lower Due to AI-Related Fears Despite Reporting In-Line Results

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Select Fund” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. It is a non-diversified fund that focuses on long-term capital appreciation by investing in common stocks of U.S. and non-U.S. companies. In the first quarter, the fund (Investor Class) delivered a return of -8.12%, lagging behind the benchmark, the MSCI World Index’s -3.57% return. Energy and industrials were the top performance contributors at the sector level, while health care and consumer discretionary detracted from performance. In addition, you can check the Fund’s top five holdings to determine its best picks for 2026.

In its first-quarter 2026 investor letter, Oakmark Global Select Fund highlighted IQVIA Holdings Inc. (NYSE:IQV). IQVIA Holdings Inc. (NYSE:IQV) is a US-based provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. On April 14, 2026, IQVIA Holdings Inc. (NYSE:IQV) closed at $175.31 per share. One-month return of IQVIA Holdings Inc. (NYSE:IQV) was 6.29%, and its shares gained 19.59% over the past 52 weeks. IQVIA Holdings Inc. (NYSE:IQV) has a market capitalization of $30.14 billion.

Oakmark Global Select Fund stated the following regarding IQVIA Holdings Inc. (NYSE:IQV) in its Q1 2026 investor letter:

“IQVIA Holdings Inc. (NYSE:IQV) was the top detractor during the quarter. The U.S.-headquartered provider of clinical research services, analytics, and solutions saw the price of its stock decline on AI-related fears despite reporting an in-line fourth quarter and 2026 outlook. Management believes the demand environment has stabilized and leading growth indicators, such as bookings and win rates, are encouraging. They expect IQVIA to be a net beneficiary of AI due to proprietary data, domain expertise, and regulatory and compliance barriers, among other factors. We continue to view IQVIA as a stable, long-cycle business that will benefit from a recovery in client spending in the coming quarters.”

IQVIA Holdings (IQV) Snaps 2-Day Losses on Higher-than-Expected Earnings

IQVIA Holdings Inc. (NYSE:IQV) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 69 hedge fund portfolios held IQVIA Holdings Inc. (NYSE:IQV) at the end of the fourth quarter, up from 61 in the previous quarter. While we acknowledge the risk and potential of IQVIA Holdings Inc. (NYSE:IQV) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IQVIA Holdings Inc. (NYSE:IQV) and that has 10,000% upside potential, check out our report about this cheapest AI stock.

In another article, we covered IQVIA Holdings Inc. (NYSE:IQV) and shared Billionaire David Tepper’s small and midcap stock picks with huge upside potential. In addition, please check out our hedge fund investor letters Q1 2026 page for more investor letters from hedge funds and other leading investors.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. This article is originally published at Insider Monkey.